News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • The American Society of Hematology will present the 2011 Wallace H. Coulter Award for Lifetime Achievement in Hematology to David G. Nathan, MD, for his career combining outstanding teaching, pioneering research, and excellence in clinical care.

Tags: Honors

  • Ken Anderson, MD, briefed members of Congress and their legislative staffs on blood cancer care and research, and the importance of protecting and enhancing federal research funding.

Tags: Grants, MultipleMyeloma

  • Androgen deprivation therapy — one of the most common treatments for prostate cancer — may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions.

Tags: ProstateCancer

  • Researchers at Dana-Farber Cancer Institute have found a previously unknown molecular pathway in mice that spurs the growth of new blood vessels when body parts are jeopardized by poor circulation.

Tags: BasicResearch

  • The use of monoclonal antibodies to activate an immune-system response to abnormal cells resulted in a significant increase in survival time in patients with metastatic melanoma, report Dana-Farber researchers.

Tags: ImmuneSystem, Melanoma, TranslationalResearch

  • Combination of cell-killing drug and monoclonal antibody slowed or halted tumor growth in almost half a group of patients whose cancers had become resistant to standard treatments.

Tags: Antibody, BreastCancer

  • Studies in zebrafish show that a 50-year-old antipsychotic medication can actively combat the cells of a difficult-to-treat form of acute lymphoblastic leukemia (ALL).

Tags: Leukemia

  • Elevated levels of anxiety may cause women with ductal carcinoma in situ (DCIS), the most common form of non-invasive breast cancer, to overestimate their risk of recurrence or dying from breast cancer, suggests a study led by Dana-Farber researchers.

Tags: BreastCancer

  • The FDA's approval of Provenge®, a prostate cancer vaccine, marks a new era of using patients' immune systems to treat cancer.

Tags: ImmuneSystem, ProstateCancer, TranslationalResearch, Immunotherapy

  • Two Dana-Farber researchers have been given an award for young investigators who are advancing the field of cancer research. Scott Armstrong, MD, PhD, is being recognized for achievements in cancer stem cell research and genomics; Kornelia Polyak, MD, PhD, for her pioneering discoveries in breast tissue.

Tags: BasicResearch, Honors, TranslationalResearch

Showing 21-30 of 484 items